Evidence review
What Compounded GLP-1 Costs Per Month
Compounded semaglutide runs roughly $93–$249/mo and tirzepatide about $125–$399/mo across the providers we track. Here is how to read the pricing.
On this page
The Verdict's #1 pick
CoreAge Rx
Grade AThe most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
See the verdict- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Access
- Compounded
Advertising disclosure · we may earn a commission at no extra cost to you. It never changes what we write about a product or its Verdict Score.
Also ranked
HumeCare+
Grade CHumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company.
Visit HumeCare+Compounded GLP-1 pricing is all over the map, and that is by design — providers use a low sticker to win the click. Across the providers we track, compounded semaglutide runs roughly $93 to $249 a month, and compounded tirzepatide roughly $125 to $399 a month. Those figures reflect each provider's published pricing at last review (2026); always confirm the current rate on the provider's own site before you buy.
The three price tiers
**The value tier (semaglutide under ~$130, tirzepatide under ~$170).** This is where the aggressive flat-price operators live. In our ranking, Ondra Health lists among the lowest disclosed semaglutide at about $93/mo, and Trimi Health carries the cheapest disclosed tirzepatide at about $125/mo. Several others — Alan Meds and bmiMD near $99 semaglutide — sit here too. The trade-off in this tier is often verification: some of the cheapest names are not LegitScript-certified, which shifts the vetting burden onto you.
**The mid-market (semaglutide ~$149–$199, tirzepatide ~$199–$349).** This is the honest middle. CoreAge Rx, for example, prices at $149 semaglutide and $349 tirzepatide flat, all 50 states, with a clean cancellation. Precision Telemed sits near $149/$199, and Curex charges one flat $199 for either molecule. You pay a little more than the value tier and, in return, generally get verified pharmacies and nationwide access.
**The premium tier (semaglutide ~$249, tirzepatide up to ~$399).** Names like Peak Wellness and Henry Meds sit at the top for compounded-only care, and Fella Health's tirzepatide reaches about $399/mo. A premium price is only defensible when something justifies it — a broad formulary, brand-name access, standout support. When it does not, our score says so.
Watch for the teaser-rate trap
The number that matters is the ongoing monthly price, not the introductory one. A "first month $99" that resets to $299 on the second charge is a $299 program. Before you commit, find the recurring price and the terms in writing — we sorted the whole ranking that way in the cash-price ruling, once with every advertised figure and once with the conditional ones struck out. If you would rather have the arithmetic done for you, the true cost calculator applies each provider's own step-ups and term commitments across whatever horizon you pick, and prints the gap between the sticker and the bill. This is why price honesty is one of the two heaviest factors in our Verdict Score methodology — a low sticker with a hidden step-up scores worse than a higher, honest flat rate, and our explainer on how the grading works shows exactly how much of the score that one factor moves.
A second version of the same trap does not reset at all — it is simply never advertised. A program can headline "as low as $199/mo" for semaglutide and "$299/mo" for tirzepatide when both figures are the twelve-month rung, charge $349 and $399 to anyone paying a single month, and bill the discounted term as one payment rather than twelve. What a headline rate looks like when the monthly rung is filtered out walks through one program whose own shop-price code drops the one-month plan before picking a number to advertise. Two questions defuse both versions: what does one month cost, and is the long plan charged monthly or all at once.
A third version leaves the first question with no answer at all, because the monthly rung does not exist. A "$199/mo average" that is really $597 charged every twelve weeks is one we ruled on in August 2026: the checkout offers no cadence choice, the advertised figure is a prepay divided by three, and the second charge lands four weeks after a $139 first one. When a page quotes an "average" rather than a price, that word is usually doing work — ask what the actual charge is and how often it repeats.
August 2026 produced three fresh specimens of the same reflex, from providers we screened but do not rank. The mildest is a $100-off first order presented as a standing rate, where the recurring price is $209 and the advertised one is $109. The strangest is a $99 headline sitting above a per-dose ladder the site never renders, a contradiction inside one company's own data that we could not resolve in either direction. And the most expensive is a provider that prints a per-month price while billing every four weeks — thirteen charges a year against a page that says twelve, and a tirzepatide tier that cannot be bought monthly at all.
What else stacks onto the price
Read for these: separate membership or "platform" fees, consultation charges billed apart from the medication, lab-work fees, and shipping. The cleanest providers fold everything into one all-in monthly number. When they don't, add the extras before you compare. Concentration is worth asking about too, not just price: compounded vials vary by compounder, and the FDA has tied that variability directly to real dosing errors when patients assume their vial matches a number they saw quoted elsewhere.
One more that is rarely accounted for: **dose**. Reaching a maintenance dose takes months, and a flat program price does not fall while you are below it — so the early months are the expensive ones per milligram, and a provider that tiers by dose can quote a headline rate you will never actually pay once you are at target. The titration planner shows how many billing months the climb takes and what they cost. Titration pace is not just a pricing question either — climbing faster than the label intends is one of the more likely reasons someone notices "Ozempic face" or hits a plateau sooner than the trials would predict, so a provider quietly under-dosing you to protect its own margin can cost you on both fronts.
Compounded vs brand-name on cost
Compounded is the affordability play. Brand-name Wegovy and Zepbound are FDA-approved but typically cost substantially more out of pocket, which is the whole reason the compounded market exists. Just keep the regulatory reality in view: compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality1. Weigh that trade in compounded vs brand-name GLP-1 and vet the pharmacy using is compounded semaglutide legit and safe.
The bottom line on price
Tirzepatide sits in a tier of its own on price, which is why we rule on it separately in best tirzepatide providers, with the twelve-month cost printed beside every monthly one. Cheapest is not the goal; cheapest-that's-verified-and-honest is. A $99 sticker from an unverified operator is not obviously a better deal than a $149 flat rate from a LegitScript-certified, all-50-states provider. Start from the ranked reviews, where price sits next to verification and access instead of standing alone.
Frequently asked questions
How much does compounded semaglutide cost per month?
Across the providers we track, roughly $93 to $249 a month, depending on the provider, dose, and whether the price is a true flat rate. Figures reflect published pricing at last review (2026).
How much does compounded tirzepatide cost per month?
Roughly $125 to $399 a month across our ranking. Tirzepatide usually costs more than semaglutide at the same provider, though a few price the two identically.
Is the cheapest provider the best deal?
Not necessarily. The cheapest sticker sometimes comes from an unverified pharmacy or hides a teaser rate. Weigh price against verification and honest terms, not in isolation.
References
The source below is cited in full, and this guide sits alongside the rest of our evidence library, where every claim about the medicine traces to a trial, a label or the regulatory record.
- U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers (503A and 503B). FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
How to Choose a GLP-1 Telehealth Provider
A decisive 8-point checklist for picking a GLP-1 telehealth provider: the molecule, honest pricing, real prescribers, verification, and a clean exit.
ReadCompounded vs Brand-Name GLP-1: Which Should You Choose?
Brand-name GLP-1 is FDA-approved and consistent; compounded is cheaper and more available but not FDA-approved. Here is how to decide honestly.
ReadIs Compounded Semaglutide Legit and Safe?
Compounded semaglutide is legal but not FDA-approved. Safety hinges on the pharmacy. Here is how to tell a legitimate program from a risky one.
ReadWhat the End of GLP-1 Compounding Means for You
The FDA shortage that made compounded semaglutide and tirzepatide widely available is over. Here is who can still get compounded GLP-1 and who must switch.
ReadDo GLP-1 Weight-Loss Patches Actually Work?
Semaglutide and tirzepatide are peptides roughly 8–10x too large to cross intact skin. Here is the pharmacology behind why a GLP-1 patch cannot work.
ReadCompounded Semaglutide Dosing Errors: What the FDA Safety Alert Says
The FDA has received reports of hospitalizations from dosing errors with compounded semaglutide vials. Here is exactly what goes wrong, and how to avoid it.
Read